Skip directly to page options Skip directly to A-Z link
Volume 17, Number 10—October 2011
Research

Multidrug-Resistant Tuberculosis, People’s Republic of China, 2007–2009

Guang Xue He1Comments to Author , Hai Ying Wang1, Martien W. Borgdorff, Dick van Soolingen, Marieke J. van der Werf, Zhi Min Liu, Xue Zheng Li, Hui Guo, Yan Lin Zhao, Jay K. Varma, Christopher P. Tostado, and Susan van den Hof

Author affiliations: Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China (G.X. He, H. Guo, Y.L. Zhao); University of Amsterdam, Amsterdam, the Netherlands (G.X. He, M.W. Borgdorff, M.J. van der Werf, S. van den Hof); Shandong Provincial Tuberculosis Control Center, Jinan, People’s Republic of China (H.Y. Wang, Z.M. Liu, X.Z. Li); National Institute for Public Health and the Environment, Bilthoven, the Netherlands (D. van Soolingen); KNCV Tuberculosis Foundation, The Hague, the Netherlands (M.J. van der Werf, S. van den Hof); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J.K. Varma); Tsinghua University, Beijing (C.P. Tostado)

Main Article

Figure 1

The allelic diversity of each VNTR loci (h) and the discriminating power according to the Hunter-Gaston index (HGI) were calculated by using this algorithm (32). MIRU-VNTR, mycobacterial interspersed repetitive unit–variable number of tandem repeats; xi, the frequency of allele i; n, total no. of strains in the scheme; N, total number of strains in the typing scheme; s, total no. of different MIRU-VNTR patterns, nj, no. of strains belonging to the jth type.

Figure 1. The allelic diversity of each VNTR loci (h) and the discriminating power according to the Hunter-Gaston index (HGI) were calculated by using this algorithm (32). MIRU-VNTR, mycobacterial interspersed repetitive unit–variable number of tandem repeats; xi, the frequency of allele i; n, total no. of strains in the scheme; N, total number of strains in the typing scheme; s, total no. of different MIRU-VNTR patterns, nj, no. of strains belonging to the jth type.

Download

Main Article

References
  1. World Health Organization. Anti-tuberculosis drug resistance in the world: fourth global report. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002–2007; 2010 [cited 2011 Apr 27]. http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf
  2. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009; 2009 [cited 2011 Apr 27]. http://whqlibdoc.who.int/publications/2009/9789241563802_eng_doc.pdf
  3. Ministry of Health of the People’s Republic of China. Nationwide anti-tuberculosis drug resistant baseline surveillance in China (2007–2008) [in Chinese]. Beijing: People’s Public Health Press, 2010.
  4. Crofton  J, Chaulet  P, Maher  D. Guidelines for the management of drug-resistant tuberculosis. 1997 [cited 2011 Apr 27]. http://whqlibdoc.who.int/hq/1997/WHO_TB_96.210_(Rev.1).pdf
  5. World Health Organization. The global MDR-TB & XDR-TB response plan, 2007–2008. 2007 [cited 2011 Apr 27]. http://libdoc.who.int/hq/2007/WHO_HTM_TB_2007.387_eng.pdf
  6. Shah  NS, Wright  A, Bai  GH, Barrera  L, Boulahbal  F, Martín-Casabona  N, Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis. 2007;13:380–7. DOIPubMedGoogle Scholar
  7. Kim  HR, Hwang  SS, Kim  HJ, Lee  SM, Yoo  CG, Kim  YW, Impact of extensive drug resistance on treatment outcomes in non–HIV-infected patients with multidrug-resistant tuberculosis. Clin Infect Dis. 2007;45:1290–5. DOIPubMedGoogle Scholar
  8. Mi  FL, Wang  LX, Li  L, Li  RZ, Zhang  H, Jiang  SW, Effect analysis of China Global Fund multi-drug resistant tuberculosis project. Chinese Journal of Antituberculosis. 2011;32:700–4.
  9. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update 2008; WHO/HTM/TB/2008.402. 2008 [cited 2011 Apr 28]. http://whqlibdoc.who.int/publications/2008/9789241547581_eng.pdf
  10. World Health Organization. International Union against Tuberculosis and Lung Disease. Anti-tuberculosis drug resistance in the world. Report no. 3: prevalence and trends. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Geneva: The Organization; 2004.
  11. Li  Z, Kelley  C, Collins  F, Rouse  D, Morris  SA. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. J Infect Dis. 1998;177:1030–5.PubMedGoogle Scholar
  12. Gagneux  S, Long  CD, Small  PM, Van  T, Schoolnik  GK, Bohannan  BJM. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science. 2006;312:1944–6. DOIPubMedGoogle Scholar
  13. van Doorn  HR, Claas  ECJ, Templeton  KE, van der Zanden  AGM, te Koppele Vije  A, de Jong  MD, Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3′-minor groove binder-DNA probes. J Clin Microbiol. 2003;41:4630–5. DOIPubMedGoogle Scholar
  14. Kenyon  TA, Ridzon  R, Luskin-Hawk  R, Schultz  C, Paul  WS, Valway  SE, A nosocomial outbreak of multidrug-resistant tuberculosis. Ann Intern Med. 1997;127:32–6.PubMedGoogle Scholar
  15. Bifani  PJ, Plikaytis  BB, Kapur  V, Stockbauer  K, Pan  X, Lutfey  ML, Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA. 1996;275:452–7. DOIPubMedGoogle Scholar
  16. Parwati  I, van Crevel  R, van Soolingen  D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis. 2010;10:103–11. DOIPubMedGoogle Scholar
  17. Glynn  JR, Whiteley  J, Bifani  PJ, Kremer  K, van Soolingen  D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis. 2002;8:843–9.PubMedGoogle Scholar
  18. Drobniewski  F, Balabanova  Y, Nikolayevsky  V, Ruddy  M, Kuznetzov  S, Zakharova  S, Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA. 2005;293:2726–31. DOIPubMedGoogle Scholar
  19. van Rie  A, Warren  RM, Beyers  N, Gie  RP, Classen  CN, Richardson  M, Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling “strain W” among non-institutionalized, human immunodeficiency virus–seronegative patients. J Infect Dis. 1999;180:1608–15. DOIPubMedGoogle Scholar
  20. Almeida  D, Rodrigues  C, Ashavaid  TF, Lalvani  A, Udwadia  ZF, Mehta  A. High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis. 2005;40:881–6. DOIPubMedGoogle Scholar
  21. Devaux  I, Kremer  K, Heersma  H, Van Soolingen  D. Clusters of multidrug-resistant Mycobacterium tuberculosis cases, Europe. Emerg Infect Dis. 2009;15:1052–60. DOIPubMedGoogle Scholar
  22. Devaux  I, Manissero  D, Fernandez de la Hoz  K, Kremer  K, van Soolingen  D, EuroTB network. Surveillance of extensively drug-resistant tuberculosis in Europe, 2003–2007. Euro Surveill. 2010;15:pii:19518.
  23. van Soolingen  D, Kremer  K. Findings and ongoing research in the molecular epidemiology of tuberculosis [in Japanese]. Kekkaku. 2009;84:83–9.PubMedGoogle Scholar
  24. van Embden  JD, Cave  MD, Crawford  JT, Dale  JW, Eisenach  KD, Gicquel  B, Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31:406–9.PubMedGoogle Scholar
  25. Supply  P, Allix  C, Lesjean  S, Cardoso-Oelemann  M, Rüsch-Gerdes  S, Willery  E, Proposal for standardization of optimized mycobacterial interspersed repetitive unit–variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006;44:4498–510. DOIPubMedGoogle Scholar
  26. Brosch  R, Gordon  SV, Marmiesse  M, Brodin  P, Buchrieser  C, Eiglmeier  K, A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A. 2002;99:3684–9. DOIPubMedGoogle Scholar
  27. Tsolaki  AG, Gagneux  S, Pym  AS, Yves-Olivier  L, Goguet de la Salmoniere  Y-OL, Kreiswirth  BN, Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol. 2005;43:3185–91. DOIPubMedGoogle Scholar
  28. Deng  Y, Wang  Y, Wang  JL, Jing  H, Yu  CB, Wang  HY, Laboratory-based surveillance of extensively drug-resistant tuberculosis, China. Emerg Infect Dis. 2011;17:495–7.PubMedGoogle Scholar
  29. Sun  Q, Meng  Q, Yip  W, Yin  X, Li  H. DOT in rural China: experience from a case study in Shandong Province, China. Int J Tuberc Lung Dis. 2008;12:625–30.PubMedGoogle Scholar
  30. He  GX, Zhao  YL, Jiang  GL, Liu  YH, Xia  H, Wang  SF, Prevalence of tuberculosis drug resistance in 10 provinces of China. BMC Infect Dis. 2008;8:166. DOIPubMedGoogle Scholar
  31. van Soolingen  D, Hermans  PWM, de Haas  PEW, Soll  DR, van Embden  JDA. The occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of insertion-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol. 1991;29:2578–86.PubMedGoogle Scholar
  32. Hunter  PR, Gaston  MA. Numerical index of the discriminatory ability of typing systems: an application of Simpson’s index of diversity. J Clin Microbiol. 1988;26:2465–6.PubMedGoogle Scholar
  33. Samper  S, Iglesias  MJ, Rabanaque  MJ, Gómez  LI, Lafoz  MC, Jiménez  MS, ; The Spanish Working Group on MDR-TB. Systematic molecular characterization of multidrug-resistant Mycobacterium tuberculosis complex isolates from Spain. J Clin Microbiol. 2005;43:1220–7. DOIPubMedGoogle Scholar
  34. Rivero  A, Marquez  M, Santos  J, Pinedo  A, Sanchez  MA, Esteve  A, High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B. Clin Infect Dis. 2001;32:159–61. DOIPubMedGoogle Scholar
  35. Glynn  JR, Whiteley  J, Bifani  PJ, Kremer  K, van Soolingen  D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis. 2002;8:843–9.PubMedGoogle Scholar
  36. Almeida  D, Rodrigues  C, Ashavaid  TF, Lalvani  A, Udwadia  ZF, Mehta  A. High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis. 2005;40:881–6. DOIPubMedGoogle Scholar
  37. Li  X, Xu  P, Shen  X, Qi  LH, DeRiemer  K, Mei  J, Non-Beijing strains of Mycobacterium tuberculosis in China. J Clin Microbiol. 2011;49:392–5. DOIPubMedGoogle Scholar
  38. Drobniewski  F, Balabanova  Y, Nikolayevsky  V, Ruddy  M, Kuznetzov  S, Zakharova  S, Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA. 2005;293:2726–31. DOIPubMedGoogle Scholar
  39. Glynn  JR, Vynnycky  E, Fine  PEM. Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol. 1999;149:366–71.PubMedGoogle Scholar
  40. Murray  M. Sampling bias in the molecular epidemiology of tuberculosis. Emerg Infect Dis. 2002;8:363–9. DOIPubMedGoogle Scholar

Main Article

1These authors contributed equally to this article.

Page created: September 20, 2011
Page updated: September 20, 2011
Page reviewed: September 20, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external